DAVA vs. DOCS, PRFT, PRO, FORTY, TWKS, CINT, PERI, RMBL, TBRG, and ISSC
Should you be buying Endava stock or one of its competitors? The main competitors of Endava include Doximity (DOCS), Perficient (PRFT), PROS (PRO), Formula Systems (1985) (FORTY), Thoughtworks (TWKS), CI&T (CINT), Perion Network (PERI), RumbleOn (RMBL), TruBridge (TBRG), and Innovative Solutions and Support (ISSC). These companies are all part of the "custom computer programming services" industry.
Doximity (NASDAQ:DOCS) and Endava (NYSE:DAVA) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.
87.2% of Doximity shares are owned by institutional investors. Comparatively, 62.2% of Endava shares are owned by institutional investors. 39.4% of Doximity shares are owned by company insiders. Comparatively, 18.8% of Endava shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Doximity currently has a consensus price target of $28.73, suggesting a potential downside of 2.52%. Endava has a consensus price target of $46.41, suggesting a potential upside of 76.87%. Given Doximity's stronger consensus rating and higher possible upside, analysts plainly believe Endava is more favorable than Doximity.
Doximity has higher earnings, but lower revenue than Endava. Endava is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.
Endava received 153 more outperform votes than Doximity when rated by MarketBeat users. Likewise, 57.67% of users gave Endava an outperform vote while only 41.32% of users gave Doximity an outperform vote.
In the previous week, Doximity had 15 more articles in the media than Endava. MarketBeat recorded 18 mentions for Doximity and 3 mentions for Endava. Doximity's average media sentiment score of 1.11 beat Endava's score of 0.10 indicating that Endava is being referred to more favorably in the news media.
Doximity has a net margin of 31.04% compared to Doximity's net margin of 5.69%. Endava's return on equity of 17.44% beat Doximity's return on equity.
Doximity has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, Endava has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.
Summary
Doximity beats Endava on 10 of the 18 factors compared between the two stocks.
Get Endava News Delivered to You Automatically
Sign up to receive the latest news and ratings for DAVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DAVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools